Active Pharmaceutical Ingredients (API) Global Market to 2017- Growth in Developing Markets to Come From Cost EfficientMan...
- Market revenue data for APIs from 2005 to 2011, forecast forward for six years to 2017.- API markets in the regions of N...
Underpenetrated Markets 173.3 Global API Market Restraints 173.3.1 Economic Recession to Restrict Investment in the Pharma...
4.7.2 North America Biotech Market Revenue Share Analysis by Customer Base 614.7.3 North America Biotech Market Revenue An...
5.7.3 Asia-Pacific Biotech Market Revenue by Customer Base and Forecast to 2017 1055.8 Asia-Pacific API Market Share Analy...
6.6.3 Europe Synthetic Market Revenue by Customer Base and Forecast to 2017 1606.7 Europe Biotech Market Analysis 1626.7.1...
1.1 List of TablesTable 1: API Market, Global, Total Revenue Analysis, $m, 2005–2017 20Table 2: API Market, Global, Revenu...
Table 35: API Market, Canada, Revenue Analysis by Product Type, $m, 2005–2017 76Table 36: API Market, Canada, Revenue Shar...
Table 69: Synthetic Market, South Korea, Revenue Share Analysis by Customer Base, %,2005–2017 133Table 70: Biotech Market,...
Table 108:Biotech Market, Italy, Revenue Analysis by Customer Base, $m, 2005–2017 197Table 109:Biotech Market, Italy, Reve...
Figure 23: Synthetic API, North America, Revenue Share by Customer Base (%), 2011 53Figure 24: Synthetic Market, North Ame...
Figure 56: Biotech Market, Asia-Pacific, Revenue Share Analysis by Customer Base (%), 2011104Figure 57: Biotech Market, As...
Figure 87: Synthetic Market, Europe, Performance and Potential Analysis Grid (%), 2005–2017157Figure 88: Synthetic Market,...
Figure 125: Synthetic Market, Spain, Revenue Share by Customer Base (%), 2005–2017 213Figure 126: Biotech Market, Spain, R...
Upcoming SlideShare
Loading in...5
×

Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand

289

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
289
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
10
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand

  1. 1. Active Pharmaceutical Ingredients (API) Global Market to 2017- Growth in Developing Markets to Come From Cost EfficientManufacturing and Rising Domestic DemandReport Details:Published:November 2012No. of Pages: 221Price: Single User License – US$3500Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets toCome From Cost Efficient Manufacturing and Rising Domestic DemandSummaryGBI Research’s report, “Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growthin Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand”provides detailed insight into the global APIs market. The research presents detailed analysis andforecasts of the major economic and market trends affecting the global APIs market. The reportcontains market forecasts, product type analysis, and drivers and restraints for growth. In addition,it includes therapeutic category analysis and contract manufacturing organizations’ (CMO) growthin the region, and their influence on API manufacturing activity towards 2017. Overall, the reportpresents a comprehensive analysis of the global APIs market, covering all the major parameters.The report is built using data and information sourced from proprietary databases, primary andsecondary research and in-house analysis by GBI Research’s team of industry experts.The global APIs market was dominated by North America, which generated 35.1% of global APIrevenues in 2011. The Asia-Pacific region also saw high growth, second behind North Americawith a revenue share of 29.7% in 2011.The global APIs market revenues reached $108,613m in 2011. In the product-based segments,the synthetic market dominated the market with 82.7% of global APIs revenues.However, increasing acceptance and increasing penetration are boosting the biopharmaceuticalsdrug market in both developed and developing economies.Scope
  2. 2. - Market revenue data for APIs from 2005 to 2011, forecast forward for six years to 2017.- API markets in the regions of North America, Asia-Pacific and Europe, along with key countriessuch as the US, Canada, Japan, China, South Korea, India, Italy, Germany, France, the UK andSpain.- API industry structure and market trends, such as a shift in manufacturing and growth inbiotechnology globally.- Drivers and restraints for the global APIs market.- Detailed historical, forecast trend and share analysis of API revenues based on product types(synthetic and biotechnology APIs) at the global, regional and key country levels.- Detailed historical and forecast trends and share analysis for API revenues based on thecustomer base (generic and innovative for synthetic APIs, biosimilars and biologics for biotechAPIs) at the global, regional and key country levels.- Analysis of API revenues based on therapeutic categories at a global and regional level.Reasons to buy- Develop business strategies with the help with specific insights in the global API market.- Identify opportunities and challenges in the global API market.- Invest in the growing segments of the APIs market.- Increase future revenue and profitability with the help of insights into the future opportunities andcritical success factors in the global APIs market.- Benchmark your operations and strategies against the major players in the global APIs market.Get your copy of this report @http://www.reportsnreports.com/reports/206056-active-pharmaceutical-ingredients-api-global-market-to-2017-growth-in-developing-markets-to-come-from-cost-efficient-manufacturing-and-rising-domestic-demand.htmlMajor points covered in Table of Contents of this report include1 Table of Contents1 Table of Contents 61.1 List of Tables 101.2 List of Figures 122 Introduction 153 Global Active Pharmaceutical Ingredients Market 163.1 Global API Market Overview 163.2 Global API Market Drivers 163.2.1 Patent Expiries to Change the Dynamics of the Global API Market 163.2.2 Increased Uptake of Biologics Across Different Therapeutic Areas and GovernmentInitiatives for Biomedical Research Set to Boost API Revenues 163.2.3 Increased Mergers and Acquisitions to Drive Global Pharmaceutical Industry Growth 163.2.4 Increasing Geographical Penetration and Elderly Population to Drive Growth of the GlobalPharmaceutical and API Markets 163.2.5 Patent Expiries of Major Drugs to Support Pharmaceutical Market Revenue Growth in
  3. 3. Underpenetrated Markets 173.3 Global API Market Restraints 173.3.1 Economic Recession to Restrict Investment in the Pharmaceutical Industry 173.3.2 Limited Improvement in Pharmaceutical Manufacturing Capabilities May Reduce OverallGrowth Potential 173.3.3 Increasing Patent Expiries to Impede Growth of the Global API Market 173.3.4 Regulatory Changes to Delay the Launch of New Drugs 183.4 Global API Market Revenue Analysis and Forecast to 2017 193.4.1 Global API Market Revenue Share by Product Type 213.4.2 Global Synthetic Market Revenue Analysis and Forecast to 2017 223.4.3 Global Synthetic Market Revenue Share Analysis by Customer Base 263.4.4 Global Synthetic Market Revenue Analysis and Forecast to 2017 273.5 Global Biotech Market Analysis 293.5.1 Global Biotech Market Revenue Analysis and Forecast to 2017 293.6 Global Biotech Market Revenue Analysis by Customer Base 343.6.1 Global Biotech Market Revenue Share Analysis by Customer Base 343.6.2 Global Biotech Market Revenue Analysis and Forecast to 2017 353.7 Global Contract Manufacturing Organizations 373.7.1 Global CMO Outsourcing Process 383.7.2 Global CMO Market Drivers 393.7.3 Global CMO Market Outsourcing Benefits 403.7.4 Global CMO Market Revenues and Forecast to 2017 414 North America Active Pharmaceutical Ingredients Market 434.1 North America API Market Overview 434.2 North America API Market Drivers 434.2.1 Continuous Growth in the Pharmaceutical Industry to Sustain API Market Growth in NorthAmerica 434.2.2 Generic Sector Supports the Growth of the North American API Market 434.2.3 Increasing Focus on Biological Drugs to Support API Market Revenue Growth 434.3 North American API Market Restraints 444.3.1 Recent Economic Slowdown has Restricted Pharmaceutical Industry Growth 444.3.2 High Cost of New Drug Development Hampers Innovation 444.3.3 Patent Expiries of Blockbuster Molecules to Contain API Market Growth in North America 444.4 North America API Market Revenue Analysis and Forecast to 2017 454.5 North America API Market Revenue Share Analysis by Product Type 474.6 North America Synthetic Market Analysis 484.6.1 North America Synthetic Market Revenue Analysis and Forecast to 2017 484.6.2 North America Synthetic Market Revenue Share Analysis by Customer Base 534.6.3 North America Synthetic Market Revenue Analysis by Customer Base and Forecast to 2017544.7 North America Biotech Market Analysis 564.7.1 North America Biotech Market Revenue Analysis and Forecast to 2017 56
  4. 4. 4.7.2 North America Biotech Market Revenue Share Analysis by Customer Base 614.7.3 North America Biotech Market Revenue Analysis by Customer Base and Forecast to 2017624.8 North America API Market Revenue Share Analysis by Therapeutic Applications 644.9 The US Active Pharmaceutical Ingredients Market 654.9.1 The US API Market Overview 654.9.2 The US API Market Revenue by Product Type and Forecast to 2017 664.9.3 The US API Market Revenue Share Analysis by Product Type and Forecast to 2017 684.9.4 The US API Market by Customer Base 694.10 Canada Active Pharmaceutical Ingredients Market 754.10.1 Canada API Market Overview 754.10.2 Canada API Market Revenue Analysis by Product Type and Forecast to 2017 754.10.3 Canada API Market Revenue Share Analysis by Product Types and Forecast to 2017 774.10.4 Canada API Market by Customer Base 785 Asia-Pacific Active Pharmaceutical Ingredients Market 845.1 Asia-Pacific API Market Overview 845.2 Asia-Pacific APIs Market Drivers 855.2.1 Pharmaceutical Manufacturing Capabilities in Developing Countries such as China and Indiato Attract API Manufacture 855.2.2 Domestic Market Growth of Developing Countries in Asia-Pacific to Drive GlobalPharmaceutical Industry Growth 855.2.3 Increasing Focus on Biotech API Drugs in Asia-Pacific will Contribute to Major Asia-PacificAPI Market Growth 855.2.4 Improving Regulatory Framework in China and India is Increasing Penetration for BrandedDrugs 855.2.5 Patent Expiries of Blockbuster Drugs to Boost Market Revenues in Asia-Pacific Markets 855.3 Asia-Pacific API Market Restraints 865.3.1 Increasing Incidence of Patent Expiries to Hamper Growth for Branded API Market 865.3.2 Highly Fragmented Market to Restrict Revenue Growth for the Asia-Pacific API Market 865.3.3 Limited Improvement in Pharmaceutical Manufacturing Capabilities may Hamper OverallGrowth Potential 865.3.4 Currency Fluctuations to Hamper Value Growth of Pharmaceutical Market in Asia-PacificRegion 865.4 Asia-Pacific API Market Revenue and Forecasts to 2017 875.5 Asia-Pacific Revenue Share Analysis by Product Type 895.6 Asia-Pacific Synthetic Market 905.6.1 Asia-Pacific Synthetic Market Revenues and Forecast to 2017 905.6.2 Asia-Pacific Synthetic Market Revenue Share Analysis by Consumer Base 955.6.3 Asia-Pacific Synthetic Market Revenues by Customer Base and Forecast to 2017 965.7 Asia-Pacific Biotech Market 985.7.1 Asia-Pacific Biotech Market Revenues and Forecasts to 2017 985.7.2 Asia-Pacific Biotech Market Revenue Share Analysis by Customer Base 104
  5. 5. 5.7.3 Asia-Pacific Biotech Market Revenue by Customer Base and Forecast to 2017 1055.8 Asia-Pacific API Market Share Analysis by Therapeutic Applications 1075.9 Japan Active Pharmaceutical Ingredients Market 1085.9.1 Japan API Market Overview 1085.9.2 Japan API Market Revenues and Forecasts to 2017 1085.9.3 Japan API Market Revenue Share Analysis by Product Type 1105.9.4 Japan API Market by Customer Base 1115.10 China Active Pharmaceutical Ingredients Market 1175.10.1 China API Market Overview 1175.10.2 China API Market Revenues by Product Type and Forecasts to 2017 1185.10.3 China API Market Revenue Share Analysis by Product Types 1205.10.4 China API Market by Customer Base 1215.11 South Korea Active Pharmaceutical Ingredients Market 1275.11.1 South Korea API Market Overview 1275.11.2 South Korea APIs Market Revenue and Forecasts to 2017 1285.11.3 South Korea API Market Revenue Share Analysis by Product Type 1305.11.4 South Korea API Market by Customer Base 1315.12 India Active Pharmaceutical Ingredients Market 1375.12.1 India API Market Overview 1375.12.2 India API Market Revenue and Forecasts to 2017 1385.12.3 India API Market Revenue Share Analysis by Product Types 1405.12.4 India API Market by Customer Base 1416 Europe Active Pharmaceutical Ingredients Market 1476.1 Europe API Market Overview 1476.2 Europe API Market Drivers 1476.2.1 Increased CMO Opportunities Expected to Improve the Production of Generics and DriveAPI Revenue Growth in Europe 1476.2.2 Overall Growth in the Pharmaceutical Industry and Increasing Elderly Population to Drive theGrowth for the European API Market 1476.2.3 Biopharmaceutical Therapies to Support API Market Growth in Europe 1476.2.4 European Regulatory Framework to Facilitate Development of Biosimilars 1476.2.5 Differences in VAT rates on Pharma Products to Increase Parallel Trade in Europe 1476.3 Europe API Market Restraints 1486.3.1 Increased Consumption of Generics to Limit the Premium Earned from Branded Products1486.3.2 Increasing Patent Expiries to Hamper the Growth of the European API Market 1486.3.3 Price Cuts to Restrict Revenue Growth for the European API Market 1496.4 Europe API Market Revenue Analysis and Forecast to 2017 1516.5 Europe API Market Revenue Share Analysis by Product Type 1536.6 Europe Synthetic Market Analysis 1546.6.1 Europe Synthetic Market Revenue Analysis and Forecast to 2017 1546.6.2 European Synthetic Market Revenue Share Analysis by Customer Base 159
  6. 6. 6.6.3 Europe Synthetic Market Revenue by Customer Base and Forecast to 2017 1606.7 Europe Biotech Market Analysis 1626.7.1 Europe Biotech Market Revenue Analysis and Forecast to 2017 1626.7.2 Europe Biotech Market Revenue Share Analysis by Customer Base 1676.7.3 Europe Biotech Market Revenues by Customer Base and Forecast to 2017 1686.8 Europe API Market Revenue Share Analysis by Therapeutic Applications 1706.9 Germany Active Pharmaceutical Ingredients Market 1726.9.1 Germany API Market Overview 1726.9.2 Germany API Market Revenue Analysis by Product Type and Forecast to 2017 1726.9.3 Germany API Market Revenue Share Analysis by Product Type and Forecast to 2017 1746.9.4 Germany API Market by Customer Base 1756.10 France Active Pharmaceutical Ingredients Market 1816.10.1 France API Market Overview 1816.10.2 France API Market Revenue Analysis by Product Type and Forecast to 2017 1816.10.3 France API Revenue Share Analysis by Product Type and Forecast to 2017 1836.10.4 France API Market by Customer Base 1846.11 Italy Active Pharmaceutical Ingredients Market 1906.11.1 Italy API Market Overview 1906.11.2 Italy API Market Revenue Analysis by Product Type and Forecast to 2017 1906.11.3 Italy API Market Revenue Share Analysis by Product Type and Forecast to 2017 1926.11.4 Italy API Market by Customer Base 1936.12 The UK Active Pharmaceutical Ingredients Market 1996.12.1 The UK API Market Overview 1996.12.2 The UK API Market Revenue Analysis by Product Type and Forecast to 2017 1996.12.3 The UK API Market Revenue Share Analysis by Product Types and Forecast to 2017 2016.12.4 The UK API Market by Customer Base 2026.13 Spain Active Pharmaceutical Ingredients Market 2086.13.1 Spain API Market Overview 2086.13.2 Spain API Market Revenue Analysis by Product Type and Forecast to 2017 2086.13.3 Spain API Market Revenue Share Analysis by Product Types and Forecast to 2017 2106.13.4 Spain API Market by Customer Base 2117 Appendix 2177.1 Abbreviations 2177.2 Bibliography 2187.3 Market Definitions 2197.4 Methodology 2197.4.1 Coverage 2197.4.2 Secondary Research 2207.4.3 Primary Research 2207.4.4 Expert Panel Validation 2207.5 Contact Us 2217.6 Disclaimer 221
  7. 7. 1.1 List of TablesTable 1: API Market, Global, Total Revenue Analysis, $m, 2005–2017 20Table 2: API Market, Global, Revenue Share by Product Types, %, 2011 21Table 3: Synthetic Market, Global, Revenue Analysis, $m, 2005–2017 23Table 4: Synthetic Market, Global, Revenue Share Analysis by Region, %, 2011 24Table 5: Synthetic Market, Global, Revenue Share Analysis by Region, %, 2005–2017 25Table 6: Synthetic Market, Global, Revenue Share by Customer Base, %, 2011 26Table 7: Synthetic Market, Global, Revenue Analysis by Customer Base, $m, 2005–2017 28Table 8: Biotech Market, Global, Revenue Analysis, $m, 2005–2017 30Table 9: Biotech Market, Global, Revenue Share by Region, %, 2011 31Table 10: Biotech Market, Global, Revenue Share Analysis by Region, %, 2005–2017 33Table 11: Biotech Market, Global, Revenue Share Analysis by Customer Base, %, 2011 34Table 12: Biotech Market, Global, Revenue Analysis by Customer Base, $m, 2005–2017 36Table 13: CMO Market, Asia-Pacific, Fine Chemical Industry Labor Cost, $/Operator/Year, 201139Table 14: CMO Market, Global, Market Revenues, $m, 2005–2017 42Table 15: API Market, North America, Major Drugs to Lose Patent Protection, 2012–2016 44Table 16: API Market, North America, Revenue Analysis by Product Type, $m, 2005–2017 46Table 17: API Market, North America, Revenue Share by Product Type, %, 2005–2017 47Table 18: Synthetic Market, North America, Revenue Analysis, $m, 2005–2017 49Table 19: Synthetic Market, North America, Revenue Share Analysis by Countries, $m and %,2011 50Table 20: Synthetic Market, North America, Revenue Share Trend, %, 2005–2017 52Table 21: Synthetic Market, North America, Revenue Share by Customer Base, (%), 2011 53Table 22: Synthetic Market, North America, Revenue Analysis by Customer Base, $m, 2005–201755Table 23: Biotech Market, North America, Revenue Analysis, $m, 2005–2017 57Table 24: Biotech Market, North America, Revenue Share by Countries, $m and %, 2011 58Table 25: Biotech Market, North America, Revenue Share Trend, %, 2005–2017 60Table 26: Biotech Market, North America, Revenue Share Analysis by Customer Base, %, 201161Table 27: Biotech Market, North America, Revenue Analysis by Customer Base, $m, 2005–201763Table 28: API Market, North America, Revenue Split by Therapeutic Applications, %, 2011–201765Table 29: API Market, The US, Revenue Analysis by Product Type, $m, 2005–2017 67Table 30: API Market, The US, Revenue Share Analysis by Product Type, %, 2005–2017 68Table 31: Synthetic Market, The US, Revenue Analysis by Customer Base, $m, 2005–2017 70Table 32: Synthetic Market, The US, Revenue Share by Customer Base, %, 2005–2017 71Table 33: Biotech Market, The US, Revenue Analysis by Customer Base, $m, 2005–2017 73Table 34: Biotech Market, The US, Revenue Share by Customer Base, %, 2005–2017 74
  8. 8. Table 35: API Market, Canada, Revenue Analysis by Product Type, $m, 2005–2017 76Table 36: API Market, Canada, Revenue Share by Product Type, %, 2005–2017 77Table 37: Synthetic Market, Canada, Revenue Analysis by Customer Base, $m, 2005–2017 79Table 38: Synthetic Market, Canada, Revenue Share by Customer Base, %, 2005–2017 80Table 39: Biotech Market, Canada, Revenue Analysis by Customer Base, $m, 2005–2017 82Table 40: Biotech Market, Canada, Revenue Share by Customer Base, %, 2005–2017 83Table 41: API Market, Asia-Pacific, Market Revenues, $m, 2005–2017 88Table 42: API Market, Asia-Pacific, Revenue Share by Product Types, $m and %, 2011 89Table 43: Synthetic Market, Asia-Pacific, Market Revenues, $m, 2005–2017 91Table 44: Synthetic Market, Asia-Pacific, Revenue Share Analysis by Countries, $m and %, 201192Table 45: Synthetic Market, Asia-Pacific, Revenue Analysis by Countries, $m, 2005–2017 95Table 46: Synthetic Market, Asia-Pacific, Revenue Share by Customer Base, %, 2011 95Table 47: Synthetic Market, Asia-Pacific, Market Revenues by Product Types, $m, 2005–2017 97Table 48: Biotech Market, Asia-Pacific, Market Revenues, $m, 2005–2017 99Table 49: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries, $m and %, 2011100Table 50: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries, $m, 2005, 2011and 2017 103Table 51: Biotech Market, Asia-Pacific, Revenue Share Analysis by Customer Base, $m and %,2011 104Table 52: Biotech Market, Asia-Pacific, Market Revenues by Product Type, $m, 2005–2017 106Table 53: API Market, Asia-Pacific, Revenue Share Analysis by Therapeutic Applications, %,2011–2017 107Table 54: API Market, Japan, Market Revenues by Product Types, $m, 2005–2017 109Table 55: API Market, Japan, Revenue Share Analysis by Product Types, %, 2005–2017 110Table 56: Synthetic Market, Japan, Market Revenues by Customer Base, $m, 2005–2017 112Table 57: Synthetic Market, Japan, Revenue Share by Customer Base, %, 2005–2017 113Table 58: Biotech Market, Japan, Market Revenues by Customer Base, $m, 2005–2017 115Table 59: Biotech Market, Japan, Revenue Share Analysis by Customer Base, %, 2005–2017 116Table 60: API Market, China, Market Revenues by Product Type, $m, 2005–2017 119Table 61: API Market, China, Revenue Share Analysis by Product Type, %, 2005–2017 120Table 62: Synthetic Market, China, Market Revenues by Customer Base, $m, 2005–2017 122Table 63: Synthetic Market, China, Revenue Share Analysis by Customer Base, %, 2005–2017123Table 64: Biotech Market, China, Market Revenues by Customer Base, $m, 2005–2017 125Table 65: Biotech Market, China, Revenue Share Analysis by Customer Base, %, 2005–2017 126Table 66: API Market, South Korea, Market Revenues by Product Types, $m, 2005–2017 129Table 67: API Market, South Korea, Revenue Share Analysis by Product Types, %, 2005–2017130Table 68: Synthetic Market, South Korea, Market Revenues by Customer Base, $m, 2005–2017132
  9. 9. Table 69: Synthetic Market, South Korea, Revenue Share Analysis by Customer Base, %,2005–2017 133Table 70: Biotech Market, South Korea, Market Revenues by Customer Base, $m, 2005–2017 135Table 71: Biotech Market, South Korea, Revenue Share Analysis by Customer Base, %,2005–2017 136Table 72: API Market, India, Market Revenues by Product Types, $m, 2005–2017 139Table 73: API Market, India, Revenue Share Analysis by Product Types, %, 2005–2017 140Table 74: Synthetic Market, India, Market Revenues by Customer Base, $m, 2005–2017 142Table 75: Synthetic Market, India, Revenue Share Analysis by Customer Base, %, 2005–2017 143Table 76: Biotech Market, India, Market Revenues by Customer Base, $m, 2005–2017 145Table 77: Biotech Market, India, Revenue Share Analysis by Customer Base, %, 2005–2017 146Table 78: Pharmaceutical Market, Leading Five European Countries, Pricing and ReimbursementMechanism, 2011 149Table 79: API Market, Europe, Total Revenue Analysis, $m, 2005–2017 152Table 80: API Market, Europe, Revenue Share by Product Types, %, 2011 153Table 81: Synthetic Market, Europe, Revenue Analysis, $m, 2005–2017 155Table 82: Synthetic Market, Europe, Revenue Share Analysis by Countries, %, 2011 156Table 83: Synthetic Market, Europe, Revenue Share Trend, %, 2005–2017 158Table 84: Synthetic Market, Europe, Revenue Share by Customer Base, %, 2011 159Table 85: Synthetic Market, Europe, Revenue Analysis by Customer Base, $m, 2005–2017 161Table 86: Biotech Market, Europe, Revenue Analysis, $m, 2005–2017 163Table 87: Biotech Market, Europe, Revenue Share by Countries, %, 2011 164Table 88: Biotech Market, Europe, Revenue Share Trend, %, 2005–2017 166Table 89: Biotech Market, Europe, Revenue Share Analysis by Customer Base, %, 2011 167Table 90: Biotech Market, Europe, Revenue Analysis by Customer Base, $m, 2005–2017 169Table 91: API Market, Europe, Revenue Split by Therapeutic Applications, %, 2011–2017 171Table 92: API Market, Germany, Revenue Analysis by Product Types, $m, 2005–2017 173Table 93: API Market, Germany, Revenue Share by Product Type, %, 2005–2017 174Table 94: Synthetic Market, Germany, Revenue Analysis by Customer Base, $m, 2005–2017 176Table 95: Synthetic Market, Germany, Revenue Share by Customer Base, %, 2005–2017 177Table 96: Biotech Market, Germany, Revenue Analysis by Customer Base, $m, 2005–2017 179Table 97: Biotech Market, Germany, Revenue Share by Customer Base, %, 2005–2017 180Table 98: API Market, France, Revenue Analysis by Product Types, $m, 2005–2017 182Table 99: API Market, France, Revenue Share by Product Type, %, 2005–2017 183Table 100:Synthetic Market, France, Revenue Analysis by Customer Base, $m, 2005–2017 185Table 101:Synthetic Market, France, Revenue Share by Customer Base, %, 2005–2017 186Table 102:Biotech Market, France, Revenue Analysis by Customer Base, $m, 2005–2017 188Table 103:Biotech Market, France, Revenue Share by Customer Base, %, 2005–2017 189Table 104:API Market, Italy, Revenue Analysis by Product Types, $m, 2005–2017 191Table 105:API Market, Italy, Revenue Share by Product Type, %, 2005–2017 192Table 106:Synthetic Market, Italy, Revenue Analysis by Customer Base, $m, 2005–2017 194Table 107:Synthetic Market, Italy, Revenue Share by Customer Base, %, 2005–2017 195
  10. 10. Table 108:Biotech Market, Italy, Revenue Analysis by Customer Base, $m, 2005–2017 197Table 109:Biotech Market, Italy, Revenue Share by Customer Base, %, 2005–2017 198Table 110:API Market, The UK, Revenue Analysis by Product Types, $m, 2005–2017 200Table 111:API Market, The UK, Revenue Share by Product Type, %, 2005–2017 201Table 112:Synthetic Market, The UK, Revenue Analysis by Customer Base, $m, 2005–2017 203Table 113:Synthetic Market, The UK, Revenue Share by Customer Base, %, 2005–2017 204Table 114:Biotech Market, The UK, Revenue Analysis by Customer Base, $m, 2005–2017 206Table 115:Biotech Market, The UK, Revenue Share by Customer Base, %, 2005–2017 207Table 116:API Market, Spain, Revenue Analysis by Product Types, $m, 2005–2017 209Table 117:API Market, Spain, Revenue Share by Product Type, %, 2005–2017 210Table 118:Synthetic Market, Spain, Revenue Analysis by Customer Base, $m, 2005–2017 212Table 119:Synthetic Market, Spain, Revenue Share by Customer Base, %, 2005–2017 213Table 120:Biotech Market, Spain, Revenue Analysis by Customer Base, $m, 2005–2017 215Table 121:Biotech Market, Spain, Revenue Share by Customer Base, %, 2005–2017 2161.2 List of FiguresFigure 1: API Market, Global, Total Revenue Analysis ($m), 2005–2017 19Figure 2: API Market, Global, Revenue Share by Product Type (%), 2011 21Figure 3: Synthetic Market, Global, Revenue Analysis ($m), 2005–2017 22Figure 4: Synthetic Market, Global, Revenue Share Analysis (%), 2011 24Figure 5: Synthetic Market, Global, Revenue Share Analysis by Region (%), 2005–2017 25Figure 6: Synthetic Market, Global, Revenue Share by Customer Base (%), 2011 26Figure 7: Synthetic Market, Global, Revenue Analysis by Customer Base ($m), 2005–2017 27Figure 8: Biotech Market, Global, Revenue Analysis ($m), 2005–2017 29Figure 9: Biotech Market, Global, Revenue Share by Region (%), 2011 31Figure 10: Biotech Market, Global, Revenue Share Analysis by Region (%), 2005–2017 32Figure 11: Biotech Market, Global, Revenue Share Analysis by Customer Base (%), 2011 34Figure 12: Biotech Market, Global, Revenue Analysis by Customer Base ($m), 2005–2017 35Figure 13: CMO Market, Global, Process for Selection of CMO and Management of OutsourcingProject 38Figure 14: CMO Market, Asia-Pacific, Fine Chemical Industry Labor Cost ($/Operator/Year), 201139Figure 15: CMO Market Key Benefits of Outsourcing to CMOs 40Figure 16: CMO Market, Global, Market Revenue ($m), 2005-2017 41Figure 17: API Market, North America, Revenue Analysis by Product Type ($m), 2005–2017 45Figure 18: API Market, North America, Revenue Share by Product Type (%), 2005–2017 47Figure 19: Synthetic Market, North America, Revenue Analysis ($m), 2005–2017 48Figure 20: Synthetic Market, North America, Revenue Share Analysis by Countries (%), 2011 50Figure 21: Synthetic Market, North America, Performance and Potential Analysis Grid (%),2005–2017 51Figure 22: Synthetic Market, North America, Revenue Share Trend Analysis by Countries (%),2005–2017 52
  11. 11. Figure 23: Synthetic API, North America, Revenue Share by Customer Base (%), 2011 53Figure 24: Synthetic Market, North America, Revenue Analysis by Customer Base ($m),2005–2017 54Figure 25: Biotech Market, North America, Revenue Analysis ($m and %), 2005–2017 56Figure 26: Biotech Market, North America, Revenue Share by Countries (%), 2011 58Figure 27: Biotech Market, North America, Performance and Potential Analysis Grid (%),2005–2017 59Figure 28: Biotech Market, North America, Revenue Share Trend (%), 2005–2017 60Figure 29: Biotech Market, North America, Revenue Share Analysis by Customer Base (%), 201161Figure 30: Biotech Market, North America, Revenue Analysis by Customer Base ($m), 2005–201762Figure 31: API Market, North America, Revenue Split by Therapeutic Applications (%), 2011–201764Figure 32: API Market, The US, Revenue Analysis by Product Type ($m), 2005–2017 66Figure 33: API Market, The US, Revenue Share Analysis by Product Type (%), 2005–2017 68Figure 34: Synthetic Market, The US, Revenue Analysis by Customer Base ($m), 2005–2017 69Figure 35: Synthetic Market, The US, Revenue Share by Customer Base (%), 2005–2017 71Figure 36: Biotech API, The US, Revenue Analysis by Customer Base ($m), 2005–2017 72Figure 37: Biotech Market, The US, Revenue Share by Customer Base (%), 2005–2017 74Figure 38: API Market, Canada, Revenue Analysis by Product Type ($m), 2005–2017 75Figure 39: API Market, Canada, Revenue Share by Product Type (%), 2005–2017 77Figure 40: Synthetic Market, Canada, Revenue Analysis by Customer Base ($m), 2005–2017 78Figure 41: Synthetic Market, Canada, Revenue Share by Customer Base (%), 2005–2017 80Figure 42: Biotech Market, Canada, Revenue Analysis by Customer Base ($m), 2005–2017 81Figure 43: Biotech Market, Canada, Revenue Share by Customer Base (%), 2005–2017 83Figure 44: API Market, Asia-Pacific, Market Revenues ($m), 2005–2017 87Figure 45: API Market, Asia-Pacific, Revenue Share by Product Type (%), 2011 89Figure 46: Synthetic Market, Asia-Pacific, Market Revenues ($m), 2005–2017 90Figure 47: Synthetic Market, Asia-Pacific, Revenue Share Analysis by Countries (%), 2011 92Figure 48: Synthetic Market, Asia-Pacific, Performance and Potential Analysis Grid (%),2005–2017 93Figure 49: Synthetic Market, Asia-Pacific, Revenue Analysis by Countries (%), 2005–2017 94Figure 50: Synthetic Market, Asia-Pacific, Revenue Share by Customer Base (%), 2011 95Figure 51: Synthetic Market, Asia-Pacific, Revenue Trend Analysis by Product Type ($m),2005–2017 96Figure 52: Biotech Market, Asia-Pacific, Market Revenues ($m and %), 2005–2017 98Figure 53: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries (%), 2011 100Figure 54: Biotech Market, Asia-Pacific, Performance and Potential Analysis Grid (%), 2005–2017101Figure 55: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries ($m), 2005–2017102
  12. 12. Figure 56: Biotech Market, Asia-Pacific, Revenue Share Analysis by Customer Base (%), 2011104Figure 57: Biotech Market, Asia-Pacific, Market Revenues by Product Type ($m), 2005–2017 105Figure 58: API Market, Asia-Pacific, Revenue Share Analysis by Therapeutic Applications (%),2011–2017 107Figure 59: API Market, Japan, Market Revenues by Product Type ($m), 2005–2017 108Figure 60: API Market, Japan, Revenue Share Analysis by Product Types (%), 2005–2017 110Figure 61: Synthetic Market, Japan, Market Revenues by Customer Base ($m), 2005–2017 111Figure 62: Synthetic Market, Japan, Revenue Share by Customer Base (%), 2005–2017 113Figure 63: Biotech Market, Japan, Market Revenues by Customer Base ($m), 2005–2017 114Figure 64: Biotech Market, Japan, Revenue Share Analysis by Customer Base (%), 2005–2017116Figure 65: API Market, China, Market Revenues by Product Type ($m), 2005–2017 118Figure 66: API Market, China, Revenue Share Analysis by Product Type (%), 2005–2017 120Figure 67: Synthetic Market, China, Market Revenues by Customer Base ($m), 2005–2017 121Figure 68: Synthetic Market, China, Revenue Share Analysis by Customer Base (%), 2005–2017123Figure 69: Biotech Market, China, Market Revenues by Customer Base ($m), 2005–2017 124Figure 70: Biotech Market, China, Revenue Share Analysis by Customer Base (%), 2005–2017126Figure 71: API Market, South Korea, Market Revenues by Product Type ($m), 2005–2017 128Figure 72: API Market, South Korea, Revenue Share Analysis by Product Types (%), 2005–2017130Figure 73: Synthetic Market, South Korea, Market Revenues by Customer Base ($m), 2005–2017131Figure 74: Synthetic Market, South Korea, Revenue Share Analysis by Customer Base (%),2005–2017 133Figure 75: Biotech Market, South Korea, Market Revenues by Customer Base ($m), 2005–2017134Figure 76: Biotech Market, South Korea, Revenue Share Analysis by Customer Base (%),2005–2017 136Figure 77: API Market, India, Market Revenues by Product Types ($m), 2005–2017 138Figure 78: API Market, India, Revenue Share Analysis by Product Types (%), 2005–2017 140Figure 79: Synthetic Market, India, Market Revenues by Customer Base ($m), 2005–2017 141Figure 80: Synthetic Market, India, Revenue Share Analysis by Customer Base (%), 2005–2017143Figure 81: Biotech Market, India, Market Revenues by Customer Base ($m), 2005–2017 144Figure 82: Biotech Market, India, Revenue Share Analysis by Customer Base (%), 2005–2017 146Figure 83: API Market, Europe, Total Revenue Analysis ($m), 2005–2017 151Figure 84: API Market, Europe, Revenue Share by Product Types (%), 2011 153Figure 85: Synthetic Market, Europe, Revenue Analysis ($m), 2005–2017 154Figure 86: Synthetic Market, Europe, Revenue Share Analysis by Countries (%), 2011 156
  13. 13. Figure 87: Synthetic Market, Europe, Performance and Potential Analysis Grid (%), 2005–2017157Figure 88: Synthetic Market, Europe, Revenue Share Trend Analysis by Countries (%),2005–2017 158Figure 89: Synthetic Market, Europe, Revenue Share by Customer Base, (%), 2011 159Figure 90: Synthetic Market, Europe, Revenue Trend by Product Types ($m), 2005–2017 160Figure 91: Biotech Market, Europe, Revenue Analysis ($m and %), 2005–2017 162Figure 92: Biotech Market, Europe, Revenue Share by Countries (%), 2011 164Figure 93: Biotech Market, Europe, Performance and Potential Analysis Grid (%), 2005–2017 165Figure 94: Biotech Market, Europe, Revenue Share Trend (%), 2005–2017 166Figure 95: Biotech Market, Europe, Revenue Share Analysis by Customer Base (%), 2011 167Figure 96: Biotech Market, Europe, Revenue Analysis by Customer Base ($m), 2005–2017 168Figure 97: API Market, Europe, Revenue Split by Therapeutic Applications (%), 2011–2017 170Figure 98: API Market, Germany, Revenue Analysis by Product Types ($m), 2005–2017 172Figure 99: API Market, Germany, Revenue Share by Product Type (%), 2005–2017 174Figure 100: Synthetic Market, Germany, Revenue Analysis by Customer Base ($m), 2005–2017175Figure 101: Synthetic Market, Germany, Revenue Share by Customer Base (%), 2005–2017 177Figure 102: Biotech Market, Germany, Revenue Analysis by Customer Base ($m), 2005–2017 178Figure 103: Biotech Market, Germany, Revenue Share by Customer Base (%), 2005–2017 180Figure 104: API Market, France, Revenue Analysis by Product Types ($m), 2005–2017 181Figure 105: API Market, France, Revenue Share by Product Type (%), 2005–2017 183Figure 106: Synthetic Market, France, Revenue Analysis by Customer Base ($m), 2005–2017 184Figure 107: Synthetic Market, France, Revenue Share by Customer Base (%), 2005–2017 186Figure 108: Biotech Market, France, Revenue Analysis by Customer Base ($m), 2005–2017 187Figure 109: Biotech Market, France, Revenue Share by Customer Base (%), 2005–2017 189Figure 110: API Market, Italy, Revenue Analysis by Product Types ($m), 2005–2017 190Figure 111: API Market, Italy, Revenue Share by Product Type (%), 2005–2017 192Figure 112: Synthetic Market, Italy, Revenue Analysis by Customer Base ($m), 2005–2017 193Figure 113: Synthetic Market, Italy, Revenue Share by Customer Base (%), 2005–2017 195Figure 114: Biotech Market, Italy, Revenue Analysis by Customer Base ($m), 2005–2017 196Figure 115: Biotech Market, Italy, Revenue Share by Customer Base (%), 2005–2017 198Figure 116: API Market, The UK, Revenue Analysis by Product Types ($m), 2005–2017 199Figure 117: API Market, The UK, Revenue Share by Product Type (%), 2005–2017 201Figure 118: Synthetic Market, The UK, Revenue Analysis by Customer Base ($m), 2005–2017202Figure 119: Synthetic Market, The UK, Revenue Share by Customer Base (%), 2005–2017 204Figure 120: Biotech Market, The UK, Revenue Analysis by Customer Base ($m), 2005–2017 205Figure 121: Biotech Market, The UK, Revenue Share by Customer Base (%), 2005–2017 207Figure 122: API Market, Spain, Revenue Analysis by Product Types ($m), 2005–2017 208Figure 123: API Market, Spain, Revenue Share by Product Type (%), 2005–2017 210Figure 124: Synthetic Market, Spain, Revenue Analysis by Customer Base ($m), 2005–2017 211
  14. 14. Figure 125: Synthetic Market, Spain, Revenue Share by Customer Base (%), 2005–2017 213Figure 126: Biotech Market, Spain, Revenue Analysis by Customer Base ($m), 2005–2017 214Figure 127: Biotech Market, Spain, Revenue Share by Customer Base (%), 2005–2017 216Contact: sales@reportsandreports.com for more information.

×